Shin Beomsu, Lee Jin Young, Im Yunjoo, Yoo Hongseok, Park Junseon, Lee Joo Sang, Lee Ki-Young, Jeon Kyeongman
Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, Republic of Korea.
Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-Ro, Gangnam-Gu, Seoul, 06351, Republic of Korea.
J Intensive Care. 2023 Aug 3;11(1):35. doi: 10.1186/s40560-023-00683-2.
Despite the understanding of sepsis-induced extracellular vesicles (EVs), such as exosomes, and their role in intercellular communication during sepsis, little is known about EV contents such as microRNA (miRNA), which modulate important cellular processes contributing to sepsis in body fluids. This study aimed to analyze the differential expression of exosomal miRNAs in plasma samples collected from sepsis patients and healthy controls, and to identify potential miRNA regulatory pathways contributing to sepsis pathogenesis.
Quantitative real-time PCR-based microarrays were used to profile plasma exosomal miRNA expression levels in 135 patients with sepsis and 11 healthy controls from an ongoing prospective registry of critically ill adult patients admitted to the intensive care unit. The identified exosomal miRNAs were tested in an external validation cohort (35 sepsis patients and 10 healthy controls). And then, functional enrichment analyses of gene ontology, KEGG pathway analysis, and protein-protein interaction network and cluster analyses were performed based on the potential target genes of the grouped miRNAs. Finally, to evaluate the performance of the identified exosomal miRNAs in predicting in-hospital and 90-day mortalities of sepsis patients, receiver operating characteristic curve (ROC) and Kaplan-Meier analyses were performed.
Compared with healthy controls, plasma exosomes from sepsis patients showed significant changes in 25 miRNAs; eight miRNAs were upregulated and 17 downregulated. Additionally, the levels of hsa-let-7f-5p, miR-331-3p miR-301a-3p, and miR-335-5p were significantly lower in sepsis patients than in healthy controls (p < 0.0001). These four miRNAs were confirmed in an external validation cohort. In addition, the most common pathway for these four miRNAs were PI3K-Akt and mitogen-activated protein kinase (MAPK) signaling pathways based on the KEGG analysis. The area under the ROC of hsa-let-7f-5p, miR-331-3p, miR-301a-3p, and miR-335-5p level for in-hospital mortality was 0.913, 0.931, 0.929, and 0.957, respectively (p < 0.001), as confirmed in an external validation cohort. Also, the Kaplan-Meier analysis showed a significant difference in 90-day mortality between sepsis patients with high and low miR-335-5p, miR-301a-3p, hsa-let-7f-5p, and miR-331-3p levels (p < 0.001, log-rank test).
Among the differentially-expressed miRNAs detected in microarrays, the top four downregulated exosomal miRNAs (hsa-let-7f-5p, miR-331-3p miR-301a-3p, and miR-335-5p) were identified as independent prognostic factors for in-hospital and 90-day mortalities among sepsis patients. Bioinformatics analysis demonstrated that these four microRNAs might provide a significant contribution to sepsis pathogenesis through PI3K-Akt and MAPK signaling pathway.
尽管人们对脓毒症诱导的细胞外囊泡(EVs),如外泌体,以及它们在脓毒症期间细胞间通讯中的作用有所了解,但对于诸如微小RNA(miRNA)等EV成分知之甚少,这些成分可调节体液中导致脓毒症的重要细胞过程。本研究旨在分析脓毒症患者和健康对照者血浆样本中外泌体miRNA的差异表达,并确定脓毒症发病机制中潜在的miRNA调控途径。
使用基于定量实时PCR的微阵列分析了135例脓毒症患者和11名健康对照者血浆外泌体miRNA的表达水平,这些样本来自一个正在进行的重症监护病房成年重症患者前瞻性登记研究。在外部验证队列(35例脓毒症患者和10名健康对照者)中对鉴定出的外泌体miRNA进行了检测。然后,基于分组miRNA的潜在靶基因进行基因本体功能富集分析、KEGG通路分析、蛋白质-蛋白质相互作用网络和聚类分析。最后,为了评估鉴定出的外泌体miRNA在预测脓毒症患者住院和90天死亡率方面的性能,进行了受试者工作特征曲线(ROC)和Kaplan-Meier分析。
与健康对照相比,脓毒症患者的血浆外泌体中有25种miRNA出现显著变化;8种miRNA上调,17种下调。此外,脓毒症患者中hsa-let-7f-5p、miR-331-3p、miR-301a-3p和miR-335-5p的水平显著低于健康对照(p < 0.0001)。这四种miRNA在外部验证队列中得到了证实。此外,基于KEGG分析,这四种miRNA最常见的通路是PI3K-Akt和丝裂原活化蛋白激酶(MAPK)信号通路。hsa-let-7f-5p、miR-331-3p、miR-301a-3p和miR-335-5p水平用于预测住院死亡率的ROC曲线下面积分别为0.913、0.931、0.929和0.957(p < 0.001),在外部验证队列中得到了证实。此外,Kaplan-Meier分析显示,miR-335-5p、miR-301a-3p、hsa-let-7f-5p和miR-331-3p水平高低不同的脓毒症患者在90天死亡率上存在显著差异(p < 0.001,对数秩检验)。
在微阵列检测到的差异表达miRNA中,下调最明显的四种外泌体miRNA(hsa-let-7f-5p、miR-331-3p、miR-301a-3p和miR-335-5p)被确定为脓毒症患者住院和90天死亡率的独立预后因素。生物信息学分析表明,这四种微小RNA可能通过PI3K-Akt和MAPK信号通路对脓毒症发病机制有显著贡献。